From June 1, 2016, U.S. based rTMS clinical use pioneer Stanford W. Miller will lead the neuroCare Group’s expansion into North America as Managing Director.
Read more … Industry Leader and rTMS Pioneer, Stanford W. Miller, Joins neuroCare Group
The first clinical study on the effect of neurofeedback in adult patients with ADHD has been successfully carried out at the University of Tübingen.
Read more … Neurofeedback found to be a successful treatment for adults with ADHD.
Authors Christopher Davey and Andrew Chanen call for alternatives to anti-depressant medication to improve outcomes for patients suffering depression. They highlight in their article that while anti-depressants still have an important role in patient treatment, medication is more effective if given in combination with other therapies. You can read the full article here.
Read more … MJA report shows need for alternatives to anti-depressants
Workplace Editor Anna Patty of the Sydney Morning Herald explains how psychiatrists in Australia are increasingly becoming dissatisfied and find it hard to do their work with the limited resources available in hospitals and the community. The full article can be found here.
Read more … "Doctors plan to quit over lack of mental health resources"
neuroCare clinician and Neurfeedback specialist Vera Kruiver spoke to health and lifestyle magazine ForYou to explain the procedure of Neurofeedback and the advantages it has for patients.
In association with the APS Neurofeedback and Psychology Interest Group, neuroCademy hosts first symposium in Sydney, Australia, to present the latest findings on non-pharmaceutical treatments of ADHD & Depression.
neuroCare is expanding in the Netherlands with its second clinic opening in Den Haag. On April 7 the staff opened its doors to showcase the new practice to the public.
Read more … Clinic in The Hague opens its doors to the public
Oxford University researchers have found that applying electrical current tot he brain can help recovery from stroke. Their research is published in the journal Science Translational Medicine.
Read more … Electrical brain stimulation could support stroke recovery
The Neurofeedback courses offered at our neuroCademy training centres in both Munich and Nijmegen have recently received outstanding feedback for its quality in teaching and device demonstration.
Clinic in the center of Munich opens to the public to offer personalized treatment for ADHD, depression, chronic Pain and for stroke sufferers undergoing rehabilitation.
The Notified Body TÜV SÜD Product service GmbH has certified the neuroConn devices THERA PRAX® NEURO PRAX® and DC-STIMULATOR
Results from the large multicenter randomized iSPOT-D study were published in Clinical Neurophysiology demonstrating that brain activity can assist in predicting antidepressant treatment outcome to commonly used antidepressant drugs
Read more … Brain activity predicts personalized antidepressant treatment